Michael Gerckens

6PUBLICATIONS
55CO-AUTHORS
Gene and molecular therapyComputational physiologyRespiratory diseasesTissue engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 30, 2026
Letermovir in Refractory and Resistant CMV After Lung Transplantation: Therapeutic Potential and Emergence of Resistance.

|Feb 26, 2026
Lower Limit of Normal of Pulmonary Function to Define Baseline Lung Allograft Dysfunction.

Michael Gerckens, Susanne Simon, Carlo Mümmler

|Feb 26, 2025
Current Blood Eosinophilia Does Not Predict the Presence of Pulmonary Hypertension in Patients with End-Stage Lung Disease.

Michaela Barnikel, Nikolaus Kneidinger, Michael Gerckens

|Jan 11, 2024
Sfrp1 inhibits lung fibroblast invasion during transition to injury-induced myofibroblasts.

Christoph H Mayr, Arunima Sengupta, Sara Asgharpour

|Dec 06, 2023
Ex vivo tissue perturbations coupled to single-cell RNA-seq reveal multilineage cell circuit dynamics in human lung fibrogenesis.

Niklas J Lang, Janine Gote-Schniering, Diana Porras-Gonzalez

|Dec 22, 2021
Phenotypic drug screening in a human fibrosis model identified a novel class of antifibrotic therapeutics.

Michael Gerckens, Kenji Schorpp, Francesco Pelizza

Pageof 1

Frequent Collaborators

5 joint publications

Jürgen Behr

5 joint publications

Nikolaus Kneidinger

4 joint publications

Ali Önder Yildirim

2 joint publications

Laurens J De Sadeleer